Novel, human cell line‐derived recombinant factor <scp>VIII</scp> (Human‐cl rh<scp>FVIII</scp>, Nuwiq^®) in children with severe haemophilia A: efficacy, safety and pharmacokinetics

Abstract

These results in paediatric PTPs indicate that Human-cl rhFVIII is effective for the prevention and treatment of bleeds.